SE0102441L - Immunosuppressant and method of immunosupressive treatment - Google Patents

Immunosuppressant and method of immunosupressive treatment

Info

Publication number
SE0102441L
SE0102441L SE0102441A SE0102441A SE0102441L SE 0102441 L SE0102441 L SE 0102441L SE 0102441 A SE0102441 A SE 0102441A SE 0102441 A SE0102441 A SE 0102441A SE 0102441 L SE0102441 L SE 0102441L
Authority
SE
Sweden
Prior art keywords
immunosuppressant
autoantibodies
immunosupressive
treatment
production
Prior art date
Application number
SE0102441A
Other languages
English (en)
Other versions
SE0102441D0 (sv
Inventor
Joseph William Depierre
Original Assignee
Pro Symbios Lab I Stockholm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Symbios Lab I Stockholm Ab filed Critical Pro Symbios Lab I Stockholm Ab
Priority to SE0102441A priority Critical patent/SE0102441L/sv
Publication of SE0102441D0 publication Critical patent/SE0102441D0/sv
Publication of SE0102441L publication Critical patent/SE0102441L/sv
Priority to US10/406,011 priority patent/US20040077720A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0102441A 2001-07-06 2001-07-06 Immunosuppressant and method of immunosupressive treatment SE0102441L (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0102441A SE0102441L (sv) 2001-07-06 2001-07-06 Immunosuppressant and method of immunosupressive treatment
US10/406,011 US20040077720A1 (en) 2001-07-06 2003-04-03 Inhibition of antibody production employing perfluorooctanoic acid or derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102441A SE0102441L (sv) 2001-07-06 2001-07-06 Immunosuppressant and method of immunosupressive treatment

Publications (2)

Publication Number Publication Date
SE0102441D0 SE0102441D0 (sv) 2001-07-06
SE0102441L true SE0102441L (sv) 2003-01-07

Family

ID=20284779

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102441A SE0102441L (sv) 2001-07-06 2001-07-06 Immunosuppressant and method of immunosupressive treatment

Country Status (2)

Country Link
US (1) US20040077720A1 (sv)
SE (1) SE0102441L (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220045D0 (en) * 2002-08-29 2002-10-09 Cxr Biosciences Ltd Sc 211745 Methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975163A (en) * 1956-10-29 1961-03-14 Minnesota Mining & Mfg Fluorine containing organic compounds and preparation thereof
US4624851A (en) * 1983-04-22 1986-11-25 Elena Avram Treatment of symptoms of neoplastic diseases

Also Published As

Publication number Publication date
SE0102441D0 (sv) 2001-07-06
US20040077720A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
EA200200990A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы дельта человека
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
NO20056236L (no) Behandling med anti-VEGF-antistoffer
CY1115745T1 (el) Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
MY169308A (en) Treatment of tnf? related disorders
BR0011838A (pt) Elementos misturadores estáticos empilhados
DE60231439D1 (de) Mitotische kinesinhemmer
DE60234278D1 (de) Mitotische kinesin-hemmer
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
DE60208792D1 (de) Tyrosin-kinase inhibitoren
DE60329990D1 (de) Mitotische kinesin-hemmer
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE394121T1 (de) Verwendung von antikörpern gegen das muc18- antigen
ATE448232T1 (de) Substituierte heterozyklen
ATE424208T1 (de) Proteinkinaseinhibitoren
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
EA200500934A1 (ru) Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний
TR200201724T2 (tr) Antihipertansiyon ve buna bağlı belirtileri tedavi etmek için method ve formüller
DE69927286D1 (de) Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs

Legal Events

Date Code Title Description
NAV Patent application has lapsed